Abstract:
Introduction.
According to the National Institute for Health and Care Excellence (NICE),
post-COVID-19 syndrome refers to a multisystemic affection with symptoms
lasting more than 12 weeks after the onset of acute disease. Persistent headache,
with a prevalence of 18%, seems to be the fifth most common symptom in
patients with the so-called long COVID syndrome, which is characterized by
“brain fog” with cognitive disturbances, fatigue, dyspnea, myalgia and muscle
weakness, depression. The burden, characteristics, pathophysiology and
management of long COVID headache are not completely understood.
Purpose.
To evaluate clinical phenotype of post-Covid 19 persistent headache in patients
with acute headache history during the acute period of Covid 19 infection (study
published in BAMS 2021).
Material and methods
This study is a survey. People, previously involved in the national survey of
Headache in the context of the COVID 19 pandemic (conducted for 3 months in
2021), were asked to complete online a structured questionnaire. These patients
had been tested serologically Covid 19 positive for the first time- more than 9
months ago.
Results.
From 140 people previously involved in
the study "Headache in the context of
COVID 19 pandemic - the results of a
national survey", 89 patients completed
the questionnaire about the persistence of
post-Covid 19 headache, from which 30
people (33.7%) mentioned the persistence
of headache after recovery. Mostly, we
observed a moderate-severe intensity of
the headache, which was localized in
33.3% (10p) in frontal region, with a
predominantly oppressive character in
56.7% cases. In 60% cases, patients have
experienced 1-2 times/week headache
using in 5.3 ± 4.74 days/month (min 0.0;
max 15.0) drug treatment.
Conclusions.
The headache is a disabling symptom of Covid 19
infection that persists even after recovery, it is
clinically manifested by severe, moderate-severe
pain affecting young women, a clinical feature
Keywords highlighted in other previous studies.
